Mirum Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights
Mirum Pharmaceuticals Inc share price today is $88.51, up -2.44%. The stock opened at $91.085 against the previous close of $90.72, with an intraday high of $91.41 and low of $87.03.
Mirum Pharmaceuticals Inc Share Price Chart
Mirum Pharmaceuticals Inc
Mirum Pharmaceuticals Inc Share Price Performance
Mirum Pharmaceuticals Inc Institutional Holdings
Mirum Pharmaceuticals Inc Market Status
Mirum Pharmaceuticals Inc Fundamentals
Market Cap 5340.84 M
PB Ratio 17.3917
PE Ratio 0.0
Enterprise Value 5410.32 M
Total Assets 842.81 M
Volume 2231722
Mirum Pharmaceuticals Inc Company Financials
About Mirum Pharmaceuticals Inc & investment objective
Company Information Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate is LIVMARLI (maralixibat), an orally administered and minimally absorbed ileal bile acid transporter (IBAT) inhibitor that is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the United States and internationally. The company is also involved in the commercialization of Cholbam, a cholic acid capsule, which is approved as treatment for pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects and for adjunctive treatment of patients with peroxisomal disorders, including peroxisome biogenesis disorder-Zellweger spectrum disorder and Smith-Lemli-Opitz syndrome; and Chenodal, a tablet, which is approved for the treatment of radiolucent stones in the gallbladder, and under development for the treatment cerebrotendinous xanthomatosis. In addition, it develops Volixibat, an oral and minimally absorbed agent designed to inhibit IBAT, currently under Phase 2b clinical trial for the treatment of adult patients with cholestatic liver diseases; Brelovitug, for the treatment of chronic HDV infection, which is in Phase 2 clinical trial; and MRM-3379, that is in Phase 2 clinical study for the treatment of FXS. The company has a collaboration agreement with the Shire International GmbH; License Agreement with Pfizer Inc.; Sanofi-Aventis Deutschland GmbH; Novartis Pharma AG; Lonza Ltd.; Enthorin Therapeutics, LLC and Dart Neuroscience LLC; Asset Purchase Agreement with Asklepion Pharmaceuticals, LLC; License and Manufacturing Agreement with LGM Pharma; and Asset Purchase Agreement with Travere Therapeutics, Inc. The company was incorporated in 2018 and is headquartered in Foster City, California.
Organisation Biotechnology
Employees 369
Industry Biotechnology
CEO Mr. Christopher Peetz
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Mirum Pharmaceuticals Inc FAQs
What is the share price of Mirum Pharmaceuticals Inc today?
The current share price of Mirum Pharmaceuticals Inc is $88.51.
Can I buy Mirum Pharmaceuticals Inc shares in India?
Yes, Indian investors can buy Mirum Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Mirum Pharmaceuticals Inc shares in India?
You can easily invest in Mirum Pharmaceuticals Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Mirum Pharmaceuticals Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Mirum Pharmaceuticals Inc.
Can I buy fractional shares of Mirum Pharmaceuticals Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Mirum Pharmaceuticals Inc?
Mirum Pharmaceuticals Inc has a market cap of $5340.84 M.
In which sector does Mirum Pharmaceuticals Inc belong?
Mirum Pharmaceuticals Inc operates in the Biotechnology sector.
What documents are required to invest in Mirum Pharmaceuticals Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Mirum Pharmaceuticals Inc?
The PE ratio of Mirum Pharmaceuticals Inc is N/A and the PB ratio is 17.39.